Job/Unit: O30222
/KAP1
Date: 03-07-13 10:26:20
Pages: 11
Arylsulfonamides as Supramolecular Columnar Liquid Crystals
= 3.3 Hz), 131.0, 129.9 (d, JC,F = 9.3 Hz), 127.9, 120.9, 116.4 (d,
JC,F = 22.5 Hz), 112.2, 111.4, 69.6, 69.3, 49.2, 44.4, 32.0, 29.8,
29.77, 29.5, 29.2, 29.1, 26.1, 22.8, 14.2 ppm. 19F NMR (235 MHz,
25 mL) heated to reflux was slowly added a solution of 6a (0.49 g,
0.37 mmol) and (2E)-1,4-dibromo-2-butene (0.09 g. 0.40 mmol) in
CH3CN/THF (40 mL/15 mL). After the addition, the mixture was
heated to reflux for 24 h. The salts were filtered off, and the solid
CDCl ): δ = 105.6 ppm. IR (ATR): ν =3313, 2918, 2850, 1589,
˜
3
1508, 1323, 1259, 1140, 1091, 833 cm–1. HRMS (MALDI+): m/z was washed with hot CH3CN. The solvent from the filtrates was
calcd. for C74H124FNaN3O10S3 [M + Na]+ 1352.8325; found
1352.8310.
evaporated and the residue was purified by column chromatog-
raphy (hexane/EtOAc, 8:2) to give 7a, yield 0.37 g (73%). 1H NMR
(250 MHz, CDCl3): δ = 7.78 (dd, J = 8.9, JH,F = 5.1 Hz, 2 H), 7.31
(dd, J = 8.4, JH,F = 1.9 Hz, 2 H), 7.14 (m, 4 H), 6.91 (d, J = 8.5 Hz,
2 H), 4.01 (q, J = 6.7 Hz, 8 H), 5.58 (s, 6 H), 3.66 (s, 12 H), 1.81
(s, 8 H), 1.43 (m, 8 H), 1.25 (complex signal group, 64 H), 0.86 (t,
J = 6.3 Hz, 12 H) ppm. 13C NMR (62.5 MHz, CDCl3): δ = 163.1
(d, JC,F = 255.1 Hz), 153.0, 149.2, 135.4 (d, JC,F = 2.6 Hz), 130.3,
130.0, 129.8 (d, JC,F = 9.5 Hz), 129.6, 129.1, 121.0, 116.3 (d, JC,F
= 22.6 Hz), 112.4, 111.8, 69.6, 69.3, 50.8, 50.7, 32.0, 29.8, 29.7,
29.6, 29.5, 29.4, 29.2, 29.1, 26.0, 22.7, 21.2, 14.2 ppm. 19F NMR
(E,E)-6-[(4-Cyanophenyl)sulfonyl]-1,11-bis{[(3,4-didodecyloxy)-
phenyl]sulfonyl}-1,6,11-triazaundeca-3,8-diene (6b): Isolated yield:
0.19 g (99%). 1H NMR (250 MHz, CDCl3): δ = 7.91 (d, J = 8.6 Hz,
2 H), 7.83 (d, J = 8.6 Hz, 2 H), 7.42 (dd, J = 8.6, 2.2 Hz, 2 H),
7.33 (d, J = 2.2 Hz, 2 H), 6.90 (d, J = 8.6 Hz, 2 H), 5.61 (app. q, J
= 4.9 Hz, 4 H), 4.96 (t, J = 6.3 Hz, 2 H, NH), 4.03 (t, J = 6.8 Hz,
4 H), 3.98 (t, J = 6.8 Hz, 4 H), 3.76 (m, 4 H), 3.49 (app. t, J =
5.1 Hz, 4 H), 1.96–1.73 (complex signal group, 8 H), 1.48–1.28
(complex signal group, 72 H), 0.88 (t, J = 6.6 Hz, 12 H) ppm. 13C
NMR (62.5 MHz CDCl3): δ = 152.9, 149.3, 144.1, 133.2, 130.9,
130.8, 127.8, 127.4, 120.9, 112.1, 111.4, 69.6, 69.3, 49.6, 44.2, 32.0,
(235 MHz, CDCl ): δ = 105.6 ppm. IR (ATR): ν =2920, 2851,
˜
3
1587, 1508, 1466, 1329, 1261, 1230, 1139, 1091, 904 cm–1. MS
(MALDI+) (dithranol): m/z calcd. for C78H128FN3O10S3 [M]+
1381.87; found 1404.9 [M + Na]+. C78H128FN3O10S3 (1383.06):
calcd. C 67.74, H 9.33, N 3.04; found C 67.91, H 9.14, N 3.13.
29.8, 29.5, 29.2, 29.1, 26.1, 22.8, 14.2 ppm. IR (ATR): ν = 3272,
˜
2918, 2849, 2359, 1586, 1510, 1322.1263, 1137, 1091, 629 cm–1
.
MALDI-TOF MS (dithranol): m/z calcd. for C75H124N4O10S3
[M]+ 1336.9; found 1337.8 [M]+, 1359.8 [M + Na]+, 1375.8 [M +
K]+. C75H124N4O10S3 (1338.01): calcd. C 67.32, H 9.34, N 4.19;
found C 67.48, H 9.56, N 4.33.
(E,E,E)-1-[(4-Cyanophenyl)sulfonyl]-6,11-bis{[(3,4-didodecyloxy)-
phenyl]sulfonyl}-1,6,11-triazacyclopentadeca-3,8,13-triene (7b):
Compound 7b was not purified by column chromatography. The
residue obtained after evaporation of the solvent was suspended in
a mixture of diethyl ether/methanol (1:1), then filtered and dried to
(E,E)-6-[(4-Aminophenyl)sulfonyl]-1,11-bis{[(3,4-didodecyloxy)-
phenyl]sulfonyl}-1,6,11-triazaundeca-3,8-diene (6c): Isolated yield:
0.54 g (91%). 1H NMR (250 MHz, CDCl3): δ = 7.53 (d, J = 8.3 Hz,
2 H), 7.42 (dd, J = 8.3, 2.0 Hz, 2 H), 7.31 (d, J = 2.0 Hz, 2 H),
6.90 (d, J = 8.3 Hz, 2 H), 6.69 (d, J = 8.8 Hz, 2 H), 5.54 (br. s, 4
H), 4.75 (t, J = 6.4 Hz, 2 H, NH), 4.15 (br. s, 2 H, NH2), 4.03 (t,
J = 6.6 Hz, 4 H), 3.98 (t, J = 6.6 Hz, 4 H), 3.65 (m, 4 H), 3.46 (m,
4 H), 1.85–1.75 (complex signal group, 8 H), 1.38–1.22 (complex
signal group, 72 H), 0.87 (t, J = 6.5 Hz, 12 H) ppm. 13C NMR
(62.5 MHz CDCl3): δ = 152.9, 150.7, 149.3, 131.1, 129.5, 128.6,
127.9, 121.0, 114.3, 112.3, 111.6, 69.7, 69.4, 68.1, 49.3, 44.5, 32.1,
1
obtain pure compound 7b. Isolated yield: 0.04 g (50%). H NMR
(250 MHz, CDCl3): δ = 7.89 (app. d, J = 8.5 Hz, 2 H), 7.86 (app. d,
J = 8.5 Hz, 2 H), 7.33 (dd, J = 8.4, 2.1 Hz, 2 H), 7.22 (d, J =
2.1 Hz, 2 H), 6.92 (d, J = 8.4 Hz, 2 H), 5.63 (s, 6 H), 4.04 (t, J =
6.8 Hz, 4 H), 4.01 (t, J = 6.5 Hz, 4 H), 3.75 (d, J = 4.7 Hz, 4 H),
3.66 (s, 8 H), 1.95–1.68 (m, 8 H), 1.54–1.39 (m, 8 H), 1.27 (s, 64
H), 0.88 (t, J = 6.5 Hz, 12 H) ppm. 13C NMR (62.5 MHz CDCl3):
δ = 153.2, 149.4, 144.0, 133.2, 130.8, 130.4, 129.9, 128.6, 127.9,
121.2, 117.4, 116.6, 112.6, 112.2, 69.9, 69.5, 51.1, 50.9, 50.7, 32.1,
28.83, 29.79, 29.6, 29.5, 29.3, 29.2, 26.2, 22.8, 14.2 ppm. IR (ATR):
29.8, 29.5, 29.3, 29.1, 26.1, 25.8, 22.8, 14.3 ppm. IR (ATR): ν =
˜
ν = 2920, 2851, 2231, 1586, 1508, 1329, 1261, 1155, 1137, 1090,
˜
3491, 3381, 3272, 2917, 2849, 1742, 1586, 1317, 1135, 736,
679 cm–1. C74H126N4O10S3 (1328.01): calcd. C 66.93, H 9.56, N
4.22, S 7.24; found C 66.80 and 66.85, H 9.68 and 9.70, N 4.30
and 4.34, S 6.80 and 6.75.
906, 721 cm– 1. MALDI-TOF MS (dithranol): calcd. for
C79H128N4O10S3 [M]+ 1388.9; found 1412.8, [M + Na]+.
C79H128N4O10S3 (1390.08): calcd. C 68.26, H 9.28, N 4.03, S 6.92;
found C 67.95, H 9.30, N 3.75, S 6.68.
(E,E)-1,11-Bis{[(3,4-didodecyloxy)phenyl]sulfonyl}-6-(phenylsulfonyl)-
1
(E,E,E)-1,6-Bis{[(3,4-didodecyloxy)phenyl]sulfonyl}-11-(phenyl)sulf-
onyl-1,6,11-triazacyclopentadeca-3,8,13-triene (7d): Isolated yield:
0.14 g (54%). 1H NMR (250 MHz, CDCl3): δ = 7.80 (d, J = 7.1 Hz,
2 H), 7.58 (m, 3 H), 7.35 (dd, J = 8.5, 2.0 Hz, 2 H), 7.24 (d, J =
2.0 Hz, 2 H), 6.94 (d, J = 8.5 Hz, 2 H), 5.56 (s, 6 H), 4.05 (dd, J =
15.0, 6.5 Hz, 8 H), 3.69 (s, 12 H), 1.93–1.78 (complex signal group,
8 H), 1.57–1.17 (complex signal group, 72 H), 0.90 (t, J = 6.5 Hz,
12 H) ppm. 13C NMR (62.5 MHz, CDCl3): δ = 153.2, 149.5, 139.5,
133.1, 130.6, 130.1, 130.0, 129.7, 129.6, 127.5, 121.3, 112.7, 112.2,
70.0, 69.6, 51.2, 32.3, 30.11, 30.10, 30.07, 30.0, 29.83, 29.8, 29.6,
1,6,11-triazaundeca-3,8-diene (6d): Isolated yield: 0.36 g (95%). H
NMR (360 MHz, CDCl3): δ = 7.77 (d, J = 7.1 Hz, 2 H), 7.54 (m,
3 H), 7.42 (dd, J = 8.5, 2.0 Hz, 2 H), 7.34 (d, J = 2.0 Hz, 2 H),
6.90 (d, J = 8.5 Hz, 2 H), 5.53 (m, 4 H), 5.24 (t, J = 6.2 Hz, 2 H,
NH), 4.02 (t, J = 6.5 Hz, 4 H), 3.96 (t, J = 6.4 Hz, 4 H), 3.69. (d,
J = 5.5 Hz, 4 H), 3.46 (t, J = 5.2 Hz, 4 H), 1.91–1.71 (complex
signal group, 8 H), 1.50–1.26 (complex signal group, 72 H), 0.89
(t, J = 6.4 Hz, 12 H) ppm. 13C NMR (90 MHz, CDCl3): δ = 152.7,
149.1, 139,7, 130.8, 129.9, 129.2, 127.9, 127.1, 120.9, 112.0, 111.3,
111.2, 69.4, 69.2, 49.0, 44.3, 31.9, 29.8, 29.7, 29.67, 29.6, 29.5, 29.4,
29.4, 26.4, 26.39, 23.1, 14.5 ppm. IR (ATR): ν = 2921, 2852, 1586,
˜
29.38, 29.1, 29.0, 26.0, 22.7, 14.2, 14.1 ppm. IR (ATR): ν = 3273,
˜
1508, 1467, 1446, 1412, 1330, 1261, 1231, 1156, 1138, 1092, 971,
908, 625 cm–1. HR-MALDI-TOF MS (dithranol/NaTFA): m/z
calcd. for C78H129N3O10S3 [M]+ 1363.884; found 1386.873 [M +
Na]+.
2919, 2850, 1586, 1509, 1464, 1414, 1393, 1320, 1263, 1232, 1153,
1135, 1090, 1047, 1022, 1001, 987, 969, 848, 761, 688, 677,
621 cm–1. HR-MALDI-TOF MS (dithranol/NaTFA): m/z calcd.
for C74H125N3O10S3 [M]+ 1311.853; found 1334.839 [M + Na]+.
Compound 7c: Prepared by following the method outlined in
Scheme 3.
Synthesis of Macrocycles 7: Compounds 7b and 7d were obtained
by following the same experimental procedure described for 7a
(Scheme 2).
(E)-N,NЈ-Bis{[(3,4-didodecyloxy)phenyl]sulfonyl}-2-buten-1,4-di-
amine (8): Compound 2 (2.63 g, 4.20 mmol) was dissolved in an-
hydrous CH3CN (100 mL), and (E)-1,4-dibromo-2-butene (0.46 g,
2.10 mmol) and K2CO3 (1.74 g, 12.6 mmol) were added. The mix-
(E,E,E)-1,6-Bis{[(3,4-didodecyloxy)phenyl]sulfonyl}-11-[(4-fluoro-
phenyl)sulfonyl]-1,6,11-triazacyclopentadeca-3,8,13-triene (7a): To a
suspension of K2CO3 (0.30 g, 2.20 mmol) in CH3CN/THF (60 mL/
Eur. J. Org. Chem. 0000, 0–0
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
9